EUCTR2020-002255-37-DE进行中（未招募）1 期
Phase 3 Follow-up Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated with Variants in the RPGR gene - Long Term Follow-Up study of Gene Therapy Trial for Patients with Retinitis Pigmentosa: RPGR
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 96
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1.Previously completed participation in Study MGT-RPGR-021.
- •2.Must reconfirm that he or she understands the purpose of, and procedures required for, the study and is willing to participate in the study.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 6
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 90
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •There are no specific exclusion criteria.
研究者
相似试验
进行中（未招募）
1 期
ong Term Follow-Up study of Gene Therapy Trial for Patients with Retinitis Pigmentosa (progressive reduction in vision) due to a gene defect on Chromosome X.X-Linked Retinitis Pigmentosa caused by mutations in the RPGR geneMedDRA version: 20.0Level: PTClassification code 10038914Term: Retinitis pigmentosaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2020-002255-37-BEJanssen-Cilag International NV96
进行中（未招募）
1 期
ong Term Follow-Up study of Gene Therapy Trial for Patients with Retinitis Pigmentosa (progressive reduction in vision) due to a gene defect on Chromosome X.X-Linked Retinitis Pigmentosa caused by mutations in the RPGR geneMedDRA version: 20.0Level: PTClassification code 10038914Term: Retinitis pigmentosaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2020-002255-37-Outside-EU/EEAMeiraGTx UK II Limited
招募中
3 期
Long Term Follow-Up study of Gene Therapy Trial for Patients with Retinitis Pigmentosa (progressive reduction in vision) due to a gene defect on Chromosome X.2024-511411-25-00Janssen Cilag International31
进行中（未招募）
1 期
ong Term Follow-Up study of Gene Therapy Trial for Patients with Retinitis Pigmentosa (progressive reduction in vision) due to a gene defect on Chromosome X.X-Linked Retinitis Pigmentosa caused by mutations in the RPGR geneMedDRA version: 20.0Level: PTClassification code 10038914Term: Retinitis pigmentosaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2020-002255-37-DKJanssen-Cilag International NV96
进行中（未招募）
1 期
ong Term Follow-Up study of Gene Therapy Trial for Patients with Retinitis Pigmentosa (progressive reduction in vision) due to a gene defect on Chromosome X.X-Linked Retinitis Pigmentosa caused by mutations in the RPGR geneMedDRA version: 20.0Level: PTClassification code: 10038914Term: Retinitis pigmentosa Class: 100000004850CTIS2024-511411-25-00Janssen Cilag International95